A.I. re-creations of the "Magnificent Ambersons" stars Joseph Cotten, Agnes Moorehead, Dolores Costello, and Tim Holt. Edward Saatchi first saw "The Magnificent Ambersons," Orson Welles's mangled masterpiece from 1942, when he was twelve years old, in the private screening room of his family's crenellated mansion, in West Sussex. Saatchi's parents had already shown him and his brother "Citizen Kane." But "Ambersons," Welles's follow-up film, about a wealthy Midwestern clan brought low, came with a bewitching backstory: R.K.O. had ripped the movie from the director's hands, slashed forty-three minutes, tacked on a happy ending, and destroyed the excised footage in order to free up vault space, leaving decades' worth of cinephiles to obsess over what might have been. Part of this outcome was the result of studio treachery, but Welles, owing to some combination of hubris and distraction, had let his film slip from his grasp. Saatchi recalled, "Around the family dinner table, that was always such a big topic: How much was Welles responsible for this? Mum was always quite tough on him." Saatchi's father, Maurice, a baron also known as Lord Saatchi, is one of two Iraqi British brothers who founded the advertising firm Saatchi & Saatchi, in 1970, which led their family to become one of the richest in the U.K. Edward's mother, Josephine Hart, who died in 2011, was an Irish writer best known for her erotic thriller "Damage," which was adapted into a film by Louis Malle. Edward, born in 1985, grew up in London and at the sprawling country estate, surrounded by palatial gardens and classical statuary. He described his parents as "movie mad." The actor and Welles biographer Simon Callow, a Saatchi family friend, recalled, "They had a cinema of their own inside the house, and it was a ritual of theirs every week to watch a film together." Aside from old movies, Edward was obsessed with "Star Trek"--especially the Holodeck, a device that conjured simulated 3-D worlds populated by characters who could interact with the members of the Starship Enterprise. That kind of wizardry didn't exist in the real world, at least not yet. But the young prince of the Saatchi castle had faith that someday it would, and that it could bring the original "Ambersons" back from oblivion. "To me, this is the lost holy grail of cinema," Saatchi told me recently, like Charles Foster Kane murmuring about Rosebud. "It just seemed intuitively that there would be some way to undo what had happened."

An AI company is to reconstruct the missing portions of Orson Welles' legendary mutilated masterwork The Magnificent Ambersons, it has been announced. According to the Hollywood Reporter, the Showrunner platform is planning to use its AI tools to assist in a recreation of the lost 43 minutes of Welles' 1942 film, removed and subsequently destroyed by Hollywood studio RKO. Edward Saatchi, CEO of interactive AI film-making studio Fable, which operates Showrunner, said in a statement to IndieWire: "We're starting with Orson Welles because he is the greatest storyteller of the last 200 years … So many people are rightly skeptical of AI's impact on cinema – but we hope that this gives people a sense of a positive contribution that AI can make for storytelling." Reports suggest that Showrunner is partnering with film-maker Brian Rose, who has been working since 2019 on an attempt to reconstruct the missing portions using animated sequences, as well as VFX expert Tom Clive. Welles started production in 1942 on The Magnificent Ambersons, an adaptation of Booth Tarkington's celebrated novel about a midwestern family in decline, as a follow-up to his Oscar-winning debut Citizen Kane.

Neuralink Corp., Elon Musk's brain-implant company, said it received approval from the US Food and Drug Administration to conduct human clinical trials. "This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people," the company said Thursday in a tweet. The FDA and Neuralink did not immediately respond to requests for comment. Musk's startup is developing a small device that will link the brain to a computer, consisting of electrode-laced wires. Placing the device requires drilling into the skull. The approval "is really a big deal," said Cristin Welle, a former FDA official and an associate professor of neurosurgery and physiology at the University of Colorado.